Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

Thursday, 5 January 2017  (2 weeks ago)
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that the underwriters of its recently announced public offering of its common stock have exercised in full their option to purchase an additional 750,000 shares. The offering, including the sale of the additional shares, is expected to close on January 9, 2017, subject to customary closing conditions. Clovis Oncology intends to use the net proceeds of the offering for general corporate purposes, including comme

Recent related news

Advertisement
THOROFARE, NJ--(Marketwired - Jan 13, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company" or "Akers Bio"), a developer of rapid health...
5 days ago • Marketwired
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company’s Board of Directors declared a common stock...
6 days ago • Business Wire
THOROFARE, NJ--(Marketwired - Jan 9, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health...
1 week ago • Marketwired
MISSION VIEJO, CA--(Marketwired - Jan 12, 2017) - Auxilio, Inc. (OTCQB: AUXO), a leading provider of complete document solutions and IT security for the...
6 days ago • Marketwired
DENVER, CO--(Marketwired - January 17, 2017) - Jagged Peak Energy Inc. (NYSE: "JAG") ("Jagged Peak") announced today that it has launched an initial public...
22 hours ago • Marketwired
LOS ANGELES--(BUSINESS WIRE)--Kilroy Realty Corporation (NYSE: KRC) today announced that it has completed its public offering of 4,427,500 shares of its common...
1 week ago • Business Wire

You might like